Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interface between pathology and epidemiology in carcinogenesis.

J S Campbell, L Tryphonas

    Toxicologic Pathology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade.

    Scientific reports·2024
    Same author

    The role of soils in the regulation of ocean acidification.

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2021
    Same author

    Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.

    Gene therapy·2018
    Same author

    The Problem of the Streptococcus: Campbell Oration delivered at Belfast on 19th January, 1933.

    The Ulster medical journal·2010
    Same author

    Mangled and missed messages.

    Canadian Medical Association journal·2010
    Same author

    Medical manpower planning.

    Canadian Medical Association journal·2010
    Same journal

    Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

    Toxicologic pathology·2026
    Same journal

    Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

    Toxicologic pathology·2026
    Same journal

    New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

    Toxicologic pathology·2026
    Same journal

    2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

    Toxicologic pathology·2026
    Same journal

    Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

    Toxicologic pathology·2026
    Same journal

    New Modalities and Carcinogenicity Assessment.

    Toxicologic pathology·2026
    See all related articles

    Toxicological studies in humans face challenges in precisely defining neoplasia. Current methods, though imperfect, are adequate for clinical action, with future advances expected from biochemical markers.

    Area of Science:

    • Toxicology
    • Oncology
    • Epidemiology

    Background:

    • Human neoplasia definition is challenging using current morphological and epidemiologic methods.
    • Toxicological studies require clear understanding of their relevance to human cancer.
    • Inconclusive or mistaken diagnoses present significant obstacles in research and clinical practice.

    Purpose of the Study:

    • To evaluate the precision of cancer diagnosis in human models.
    • To assess the utility of animal models in resolving diagnostic difficulties.
    • To determine the extent to which epidemiology can address these challenges.

    Main Methods:

    • Emphasis on human cancer models for precise diagnosis.
    • Utilizing animal models to explore similar diagnostic challenges.

    Related Experiment Videos

  • Applying epidemiologic methods to resolve uncertainties in cancer definition.

    • Main Results:

    • Existing morphological and epidemiologic methods have limitations in defining human neoplasia.
    • Animal models present some, but not all, comparable difficulties.
    • Epidemiology offers partial resolution but leaves residual unanswered questions.

    Conclusions:

    • Current methods, while imperfect, are sufficient for clinical study and action.
    • Vigilance and consultation are crucial to minimize diagnostic errors.
    • Future advancements in biochemical markers and morphometry are anticipated to improve precision.